# DIBBS #SPE2DP-27-T-0308

DLA procurement of atenolol 25 mg tablets

**Posted:** November 13, 2026
**Respond By:** November 18, 2026
**Identifier:** SPE2DP-27-T-0308
**NAICS:** 424210, 325412

DLA Troop Support is seeking a small quantity of generic atenolol tablets for Army destinations.
- Government buyer: Defense Logistics Agency (DLA), DLA Troop Support, Medical Supply Chain Pharm FSA; buyer contact: Imerah Burnett.
- Product: Atenolol tablets, 25 mg, in 100-count bottles (NSN 6505-01-336-6196); 1 bottle contains 100 tablets.
  - CLIN 1: 2 bottles.
  - CLIN 2: 1 bottle.
- Approved sources and listed part numbers: **Mylan Pharmaceuticals Inc.** (NDC00378-0218-01), **McKesson Corporation** (463649), and **Teva Pharmaceuticals USA, Inc.** (NDC00093-0787-01).
- Requirements: FDA-regulated drug, minimum 36-month non-extendable shelf life, and delivery within 20 days after order to separate Army destinations.

### Description

ATENOLOL TABLETS (QTY: 1, NSN: 6505-01-336-6196, Purchase Request: 7019117035)
  Approved Sources:
  - CAGE: 34WR5, Part No: 463649, Company: MCKESSON CORPORATION
  - CAGE: 3KJG9, Part No: NDC00378-0218-01, Company: MYLAN PHARMACEUTICALS INC
  - CAGE: 3V8D7, Part No: NDC00093-0787-01, Company: TEVA PHARMACEUTICALS USA, INC.
 
ATENOLOL TABLETS (QTY: 2, NSN: 6505-01-336-6196, Purchase Request: 7019092000)
  Approved Sources:
  - CAGE: 34WR5, Part No: 463649, Company: MCKESSON CORPORATION
  - CAGE: 3KJG9, Part No: NDC00378-0218-01, Company: MYLAN PHARMACEUTICALS INC
  - CAGE: 3V8D7, Part No: NDC00093-0787-01, Company: TEVA PHARMACEUTICALS USA, INC.
 

[View original listing](https://www.dibbs.bsm.dla.mil/rfq/rfqrec.aspx?sn=SPE2DP27T0308)